165 related articles for article (PubMed ID: 18980535)
1. Novel vaccines: bridging research, development and production.
Demirjian A; Levy O
Expert Rev Vaccines; 2008 Nov; 7(9):1321-4. PubMed ID: 18980535
[TBL] [Abstract][Full Text] [Related]
2. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 2.
Jones SD
IDrugs; 2010 Oct; 13(10):692-4. PubMed ID: 20878589
[TBL] [Abstract][Full Text] [Related]
3. New approaches in vaccine development.
Leclerc C
Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):329-41. PubMed ID: 12818620
[TBL] [Abstract][Full Text] [Related]
4. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 1.
Jones SD
IDrugs; 2010 Oct; 13(10):689-91. PubMed ID: 20878588
[TBL] [Abstract][Full Text] [Related]
5. Approaches to new vaccines.
Mahon BP; Moore A; Johnson PA; Mills KH
Crit Rev Biotechnol; 1998; 18(4):257-82. PubMed ID: 9887505
[TBL] [Abstract][Full Text] [Related]
6. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
7. Microparticles for the delivery of DNA vaccines.
O'Hagan DT; Singh M; Ulmer JB
Immunol Rev; 2004 Jun; 199():191-200. PubMed ID: 15233735
[TBL] [Abstract][Full Text] [Related]
8. Engineering DNA vaccines against infectious diseases.
Lee J; Arun Kumar S; Jhan YY; Bishop CJ
Acta Biomater; 2018 Oct; 80():31-47. PubMed ID: 30172933
[TBL] [Abstract][Full Text] [Related]
9. From empiricism to rational design: a personal perspective of the evolution of vaccine development.
De Gregorio E; Rappuoli R
Nat Rev Immunol; 2014 Jul; 14(7):505-14. PubMed ID: 24925139
[TBL] [Abstract][Full Text] [Related]
10. [Adjuvants--essential components of new generation vaccines].
Dzierzbicka K; Kołodziejczyk AM
Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
[TBL] [Abstract][Full Text] [Related]
11. Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.
Dykman LA
Expert Rev Vaccines; 2020 May; 19(5):465-477. PubMed ID: 32306785
[TBL] [Abstract][Full Text] [Related]
12. Vaccine adjuvants: key tools for innovative vaccine design.
Riese P; Schulze K; Ebensen T; Prochnow B; Guzmán CA
Curr Top Med Chem; 2013; 13(20):2562-80. PubMed ID: 24066891
[TBL] [Abstract][Full Text] [Related]
13. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
[TBL] [Abstract][Full Text] [Related]
14. The current challenges for vaccine development.
Oyston P; Robinson K
J Med Microbiol; 2012 Jul; 61(Pt 7):889-894. PubMed ID: 22322337
[TBL] [Abstract][Full Text] [Related]
15. Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.
Zhang L; Yang W; Hu C; Wang Q; Wu Y
Int J Nanomedicine; 2018; 13():2973-2987. PubMed ID: 29861631
[TBL] [Abstract][Full Text] [Related]
16. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases.
Lin R; Tarr PE; Jones TC
Clin Infect Dis; 1995 Dec; 21(6):1439-49. PubMed ID: 8749629
[TBL] [Abstract][Full Text] [Related]
17. Innovations in vaccine development: can regulatory authorities keep up?
Cox MM; Onraedt A
Expert Rev Vaccines; 2012 Oct; 11(10):1171-3. PubMed ID: 23176649
[TBL] [Abstract][Full Text] [Related]
18. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
[TBL] [Abstract][Full Text] [Related]
19. A need for effective adjuvants.
Bunce CJ; Morse MA
Curr Opin Mol Ther; 2003 Feb; 5(1):8-9. PubMed ID: 12669464
[No Abstract] [Full Text] [Related]
20. Danger, death and DNA vaccines.
Bergmann-Leitner ES; Leitner WW
Microbes Infect; 2004 Mar; 6(3):319-27. PubMed ID: 15065568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
